Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Evid Based Integr Med ; 28: 2515690X231152928, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36740925

RESUMO

Safe depigmenting agents are currently increasing in the cosmetic or pharmaceutical industry because various compounds have been found to have undesirable side effects. Therefore, the present study aimed to investigate the melanogenesis inhibitory effects of Prunus cerasoides Buch. -Ham. D. Don. flower extracts and their molecular mechanism in B16F10 mouse melanoma cells. Moreover, we also examined phenolic and flavonoid contents, antioxidant activity, chemical constituents of potential extracts, and molecular docking. The highest phenolic and flavonoid contents with the greatest scavenging activity were found in the butanol extract of the P. cerasoides flower compared to other extracts. From all extracts, only crude, diethyl ether, and butanol extracts showed an inhibition of mushroom tyrosinase activity, cellular tyrosinase activity, and melanin content as well as the downregulation of the gene expression of the microphthalmia-associated transcription factor (MITF), tyrosinase, tyrosinase-related protein-1 (TRP-1), and tyrosinase-related protein-2 (TRP-2) in α-MSH-stimulated B16F10 cells. Based on the molecular docking study, n-hexadecanoic acid, heptadecanoic acid, octadecanoic acid, 9,12-octadecadienoic acid, 9,12,15-octadecanoic acid, and eicosanoic acid might show an inhibitory effect against tyrosinase and MITF. In conclusion, this finding demonstrates that both the diethyl ether and butanol extracts of the P. cerasoides flower can effectively reduce tyrosinase activity and melanin synthesis through the downregulation of the melanogenic gene expression in B16F10 cells and through the molecular docking study. Taken together, the diethyl ether and butanol extracts of the P. cerasoides flower could be an anti-melanogenic ingredient for hyperpigmentary or melasma treatment.


Assuntos
Melanoma Experimental , Monofenol Mono-Oxigenase , Animais , Camundongos , Butanóis/uso terapêutico , Éter/uso terapêutico , Flavonoides , Melaninas/uso terapêutico , Melanoma Experimental/tratamento farmacológico , Melanoma Experimental/metabolismo , Simulação de Acoplamento Molecular , Monofenol Mono-Oxigenase/genética , Monofenol Mono-Oxigenase/metabolismo
2.
Chemotherapy ; 60(5-6): 302-9, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-26088465

RESUMO

Daucus carota (DC) is a herb used in folklore medicine in Lebanon to treat numerous diseases including cancer. Recent studies in our laboratory on DC oil and its fractions revealed potent anticancer activities in vitro and in vivo. The present study aims to investigate the effect of the most potent DC fraction, pentane/diethyl ether (50:50), on lung, skin, breast and glioblastoma cancer cell motility and invasion. Upon treatment, a pronounced decrease in cancer cell motility was observed in the 4 cell lines. The treatment also led to a decrease in cancer cell invasion and an increased cell adhesion. Additionally, the DC fraction caused a decrease in the activation of the ρ-GTPases Rac and CDC42, a finding that may partially explain the treatment-induced decrease in cell motility. The current study demonstrates a crucial effect of the DC pentane/diethyl ether fraction on cancer cell motility and metastasis, making it a potential candidate for cancer therapy specifically targeting cancer motility and metastasis.


Assuntos
Movimento Celular/efeitos dos fármacos , Daucus carota , Éter/uso terapêutico , Invasividade Neoplásica/prevenção & controle , Pentanos/uso terapêutico , Extratos Vegetais/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/patologia , Éter/isolamento & purificação , Éter/farmacologia , Feminino , Humanos , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/patologia , Melanoma Experimental , Invasividade Neoplásica/patologia , Pentanos/isolamento & purificação , Pentanos/farmacologia , Extratos Vegetais/isolamento & purificação , Folhas de Planta , Óleos de Plantas/isolamento & purificação , Óleos de Plantas/uso terapêutico , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/patologia
6.
Anat Rec ; 218(2): 116-22, 1987 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-3619078

RESUMO

Isoflurane is an inhalational anesthetic agent associated with no known hepatic toxicity. Despite this fact, isoflurane has not been widely utilized as an anesthetic agent in studies of liver structure and function in experimental animals. For this reason, livers from rats treated with pentobarbital or diethylether were compared to those from rats treated with isoflurane to determine differences in biochemical and morphologic parameters. Liver from pentobarbital-treated rats showed a significant decline in glutathione-S-transferase activity compared to liver from isoflurane/O2 or ether-treated rats. Liver microsomes from isoflurane/O2-treated rats retained more cytochrome-C(P450)-reductase activity than did those from pentobarbital-treated, ether-treated, or decapitated rats. Despite these biochemical alterations, morphometric analysis of liver from isoflurane/O2 and pentobarbital-treated rats showed no quantitative or qualitative differences in liver structure or organelle volume densities. Neither were differences detected in uptake and distribution of 125I-epidermal growth factor when analyzed by electron microscopic autoradiography. These data show that isoflurane with supplemental O2 has no effects on hepatic structure and fewer effects on hepatic function than other anesthetics and may be a better experimental anesthetic than any currently in use.


Assuntos
Anestesia Geral/veterinária , Animais de Laboratório/cirurgia , Isoflurano/uso terapêutico , Anestesia por Inalação/veterinária , Animais , Avaliação Pré-Clínica de Medicamentos/veterinária , Éter/farmacologia , Éter/uso terapêutico , Isoflurano/farmacologia , Fígado/anatomia & histologia , Fígado/citologia , Fígado/efeitos dos fármacos , Masculino , Pentobarbital/farmacologia , Pentobarbital/uso terapêutico , Ratos , Ratos Endogâmicos , Cirurgia Veterinária/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA